Free Trial
LON:DOCS

Dr. Martens (DOCS) Share Price, News & Analysis

Dr. Martens logo
GBX 59.05 -0.40 (-0.67%)
As of 04:39 AM Eastern

About Dr. Martens Stock (LON:DOCS)

Key Stats

Today's Range
58.65
59.28
50-Day Range
47.98
59.75
52-Week Range
43.02
93.25
Volume
134,712 shs
Average Volume
2.34 million shs
Market Capitalization
£573.24 million
P/E Ratio
8.37
Dividend Yield
5.08%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Dr. Martens is an iconic British brand founded in 1960 in Northamptonshire. Originally produced for workers looking for tough, durable boots, the brand was quickly adopted by diverse youth subcultures and associated musical movements. Dr. Martens have since transcended their working-class roots while still celebrating their proud heritage and, six decades later, “Docs” or “DMs” are worn by people around the world who use them as a symbol of empowerment and their own individual attitude. The Company successfully listed on the main market of the London Stock Exchange on 29 January 2021 (DOCS.L) and is a constituent of the FTSE 250 index. Dr. Martens operates across three geographic regions: EMEA, Americas and APAC. Our product segments include Originals, Fusion, Kids and Casual and a complementary range of Accessories.

Receive DOCS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Dr. Martens and its competitors with MarketBeat's FREE daily newsletter.

DOCS Stock News Headlines

Musk’s Project Colossus could mint millionaires
I predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.
See More Headlines

DOCS Stock Analysis - Frequently Asked Questions

Dr. Martens' stock was trading at GBX 72.20 at the start of the year. Since then, DOCS shares have decreased by 18.2% and is now trading at GBX 59.05.
View the best growth stocks for 2025 here
.

Dr. Martens plc (LON:DOCS) posted its earnings results on Thursday, November, 28th. The company reported ($1.30) earnings per share (EPS) for the quarter. Dr. Martens had a trailing twelve-month return on equity of 18.91% and a net margin of 7.89%.
Read the conference call transcript
.

Shares of DOCS stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Dr. Martens investors own include boohoo group (BOO), Aston Martin Lagonda Global (AML), ASOS (ASC), Vodafone Group Public (VOD), JD Sports Fashion (JD), Legal & General Group (LGEN) and Lloyds Banking Group (LLOY).

Company Calendar

Last Earnings
11/28/2024
Record date for 4/8 Dividend
3/06/2025
Ex-Dividend for 4/8 Dividend
3/06/2025
Dividend Payable
4/08/2025
Today
5/14/2025

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Footwear & Accessories
Sub-Industry
Computer Software
Current Symbol
LON:DOCS
CIK
N/A
Fax
N/A
Employees
890
Year Founded
N/A

Profitability

Trailing P/E Ratio
8.43
Forward P/E Ratio
23.03
P/E Growth
6.4
Net Income
£68.97 million
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
£874.20 million
Cash Flow
GBX 4.16 per share
Price / Cash Flow
14.29
Book Value
GBX 37.80 per share
Price / Book
1.57

Miscellaneous

Free Float
N/A
Market Cap
£577.12 million
Optionable
Not Optionable
Beta
0.11
10 Best Cheap Stocks to Buy Now Cover

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.

Get This Free Report

This page (LON:DOCS) was last updated on 5/15/2025 by MarketBeat.com Staff
From Our Partners